- Home
- APH vs MDT Comparison
APH vs MDT Comparison
Compare APH & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APH
- MDT
- Stock Information
- Founded
- APH 1932
- MDT 1949
- Country
- APH United States
- MDT Ireland
- Employees
- APH N/A
- MDT N/A
- Industry
- APH Electrical Products
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- APH Technology
- MDT Health Care
- Exchange
- APH Nasdaq
- MDT Nasdaq
- Market Cap
- APH 113.0B
- MDT 110.5B
- IPO Year
- APH 1991
- MDT N/A
- Fundamental
- Price
- APH $99.46
- MDT $88.14
- Analyst Decision
- APH Buy
- MDT Buy
- Analyst Count
- APH 11
- MDT 16
- Target Price
- APH $88.55
- MDT $98.00
- AVG Volume (30 Days)
- APH 9.1M
- MDT 8.2M
- Earning Date
- APH 07-23-2025
- MDT 08-19-2025
- Dividend Yield
- APH 0.66%
- MDT 3.21%
- EPS Growth
- APH 25.95
- MDT 30.80
- EPS
- APH 2.06
- MDT 3.61
- Revenue
- APH $16,777,400,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- APH $34.36
- MDT $6.32
- Revenue Next Year
- APH $7.93
- MDT $5.28
- P/E Ratio
- APH $48.29
- MDT $24.48
- Revenue Growth
- APH 30.70
- MDT 3.62
- 52 Week Low
- APH $54.77
- MDT $75.96
- 52 Week High
- APH $99.71
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- APH 75.96
- MDT 61.18
- Support Level
- APH $96.17
- MDT $85.22
- Resistance Level
- APH $99.01
- MDT $89.17
- Average True Range (ATR)
- APH 1.64
- MDT 1.31
- MACD
- APH -0.05
- MDT 0.14
- Stochastic Oscillator
- APH 96.72
- MDT 83.01
About APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. Amphenol holds the second-largest connector market share globally and sells into the end markets of automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks. Amphenol is diversified geographically, with operations in 40 countries.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.